Head-to-head · computed 2026-08-11
HealthRX vs MEDVi
HealthRX: HealthRX offers flat per-dose compounded GLP-1 pricing on 12-month and 3-month commitment plans. Its $99/mo semaglutide and $179/mo tirzepatide on the twelve-month plan rank among the lowest annualized figures in the market. No month-to-month rate is published. MEDVi: MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat.
Tirzepatide
| HealthRX | MEDVi | |
|---|---|---|
| All-in maintenance | $209/mo | $399/mo |
| Best plan rate | $179/mo | $399/mo |
| 12-month total | $2,148 | $4,788 |
| Status | Reported · 2026-07-18 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, HealthRX's $209 a month undercuts MEDVi's $399 by $190 a month at the 10 mg/wk maintenance basis — $2,280 across a year. HealthRX's figure is reported (captured 2026-07-18) and MEDVi's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
HealthRX's tirzepatide ladder runs $209 a month on a three-month plan, and $179 a month on a twelve-month plan. MEDVi's runs $399 a month billed monthly. On the twelve-month basis HealthRX's $2,148 beats MEDVi's $4,788 by $2,640 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| HealthRX | MEDVi | |
|---|---|---|
| All-in maintenance | $133/mo | $299/mo |
| Best plan rate | $99/mo | $299/mo |
| 12-month total | $1,188 | $3,588 |
| Status | Reported · 2026-07-18 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, HealthRX's $133 a month undercuts MEDVi's $299 by $166 a month at the 2.4 mg/wk maintenance basis — $1,992 across a year. HealthRX's figure is reported (captured 2026-07-18) and MEDVi's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
HealthRX's semaglutide ladder runs $133 a month on a three-month plan, and $99 a month on a twelve-month plan. MEDVi's runs $299 a month billed monthly. On the twelve-month basis HealthRX's $1,188 beats MEDVi's $3,588 by $2,400 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Structure, side by side
HealthRX
- MembershipNone
- Dose policyFlat — same price at every dose
- Commitment12-month or 3-month plans only; no month-to-month rate published
- CancellationPer provider terms; confirm at enrollment
- Pharmacyhealthrx.com (pharmacy partner not publicly named)
MEDVi
- MembershipNone
- Dose policyTiered on semaglutide; tirzepatide flat
- CommitmentMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner pharmacies
What our desk is watching on each
HealthRX: HealthRX publishes no month-to-month rate; the $99/mo sema and $179/mo tirz are 12-month plan rates. The lowest commitment available is the 3-month plan ($133 sema, $209 tirz). Reported status — RangeYourself verified 2026-07-18 on healthrx.com; our independent checkout is pending.
MEDVi: Start-vs-maintenance spread on semaglutide; compare on maintenance.
Questions people ask
Is HealthRX or MEDVi cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does HealthRX vs MEDVi miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do HealthRX and MEDVi cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $2,148 at HealthRX and $4,788 at MEDVi — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: HealthRX · MEDVi. Official sites: HealthRX ↗ · MEDVi ↗. Nothing here is medical advice.